Congress Urged To Address Expanded OMB Role In Regulations, Guidances
The government watchdog group OMB Watch is urging Congress to take action against an executive order that increases the administration's influence over regulations and guidance documents issued by FDA and other agencies
You may also be interested in...
The House moves to block funding for Executive Order 13422, which would increase Office of Management and Budget oversight over all federal agencies, with legislation passed June 28. Among other things, the order states that OMB has the authority to require notice and review of agency guidance documents (1"The Tan Sheet" Jan. 29, 2007, In Brief). An amendment to an appropriations bill (HR 2829) passed by the House stipulates that "none of the funds made available by this act may be used to implement" the executive order. The bill provides funding for the Treasury Department, Executive Office and general government activities. The amendment was co-sponsored by Science Subcommittee on Oversight Chair Brad Miller, D-N.C., and Judiciary Subcommittee on Commercial and Administrative Law Chair Linda Sanchez, D-Cal., who each held hearings on the executive order in February (2"The Tan Sheet" March 12, 2007, p. 10). No similar action has been taken as yet in the Senate...
Two House subcommittees are planning a joint hearing on amended 1Executive Order 12866, which institutionalizes the review of federal agency regulations and guidance documents by presidential appointees rather than career agency staff
The San Diego firm is diversifying its spinal fusion offerings with a $16 million purchase of the Formagraft synthetic bone graft product line.